Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018464HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10019018HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10020203HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10020355HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10041510HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10041511HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10044221HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10044222HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10048986HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10048987HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807